Results 131 to 140 of about 2,355 (146)
Some of the next articles are maybe not open access.

Effects of linalool and eugenol on the survival of Leishmania ( L .) infantum chagasi within macrophages

Acta Tropica, 2016
The most commonly used drugs against visceral leishmaniasis are based on pentavalent antimonial compounds, which have played a fundamental role in therapy for over 70 years. However, the treatment is painful and has severe toxic side effects that can be fatal. Antimonial resistance is spreading and reaching alarming proportions.
Fernando L, Dutra   +6 more
openaire   +2 more sources

Role of antigen‐presenting cells in non‐ulcerated skin lesions caused by Leishmania ( Leishmania ) infantum chagasi

Parasite Immunology, 2023
Carmen María Sandoval Pacheco   +2 more
exaly  

Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi

Parasite Immunology, 2022
Marcia Dalastra Laurenti   +2 more
exaly  

Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi in Central America

Parasite Immunology, 2020
Gabriela Venicia Araujo Flores   +2 more
exaly  

Co-infection by Leishmania amazonensis and L. infantum/L. chagasi in a case of diffuse cutaneous leishmaniasis in Bolivia

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002
Anne-Laure Bañuls, F Le Pont
exaly  

Botón de Oriente por Leishmania infantum (L. chagasi)

Revista Clínica Española, 2012
T. García-Lozano   +3 more
openaire   +1 more source

Preclinical diagnosis of American visceral leishmaniasis during early onset of humanLeishmania (L.) infantum chagasi-infection

Pathogens and Global Health, 2014
Patricia Karla Santos Ramos   +2 more
exaly  

Trypanosoma cruzi and Leishmania infantum chagasi Infection in Wild Mammals from Maranhão State, Brazil

Vector-Borne and Zoonotic Diseases, 2015
Andrea Pereira da Costa   +2 more
exaly  

[Oriental sore due to Leishmania infantum (L. chagasi)].

Revista clinica espanola, 2012
T, García-Lozano   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy